Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Chaisson

Showing results (211-220 of 226) with videos related to

Pageof 23
Sort By:
Antimicrobial Agents and Chemotherapy|December 1, 1991
Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency virus infectionC Flexner, P A Barditch-Crovo, D M Kornhauser, et al.
JAMA|March 16, 1990
Projections of AIDS morbidity and mortality in San FranciscoG F Lemp, S F Payne, G W Rutherford, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 17, 2015
MTBDRplus results correlate with treatment outcome in previously treated tuberculosis patientsF-L Huang, J-L Jin, S Chen, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 16, 2013
Safety and effectiveness of HAART in tuberculosis-HIV co-infected patients in BrazilA P G dos Santos, A G Pacheco, A Staviack, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 24, 2008
Contribution of reinfection to recurrent tuberculosis in South African gold minersS Charalambous, A D Grant, V Moloi, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 9, 2013
Tuberculosis control in a socially vulnerable area: a community intervention beyond DOT in a Brazilian favelaE C C Soares, W M Vollmer, S C Cavalcante, et al.
Lancet (London, England)|March 31, 1998
Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infectionN A Halsey, J S Coberly, J Desormeaux, et al.
JAMA|March 25, 2000
Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study GroupF Gordin, R E Chaisson, J P Matts, et al.
The Journal of Antimicrobial Chemotherapy|November 26, 2020
Nevirapine pharmacokinetics in HIV-infected persons receiving rifapentine and isoniazid for TB preventionA T Podany, J Leon-Cruz, J Hakim, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 17, 2009
Tuberculosis incidence among contacts of active pulmonary tuberculosisM Cailleaux-Cezar, D de A Melo, G M Xavier, et al.
Pageof 23

Showing results (211-220 of 226) with videos related to

Sort By:
Pageof 23
Antimicrobial Agents and Chemotherapy|December 1, 1991
Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency virus infectionC Flexner, P A Barditch-Crovo, D M Kornhauser, et al.
JAMA|March 16, 1990
Projections of AIDS morbidity and mortality in San FranciscoG F Lemp, S F Payne, G W Rutherford, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 17, 2015
MTBDRplus results correlate with treatment outcome in previously treated tuberculosis patientsF-L Huang, J-L Jin, S Chen, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 16, 2013
Safety and effectiveness of HAART in tuberculosis-HIV co-infected patients in BrazilA P G dos Santos, A G Pacheco, A Staviack, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 24, 2008
Contribution of reinfection to recurrent tuberculosis in South African gold minersS Charalambous, A D Grant, V Moloi, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 9, 2013
Tuberculosis control in a socially vulnerable area: a community intervention beyond DOT in a Brazilian favelaE C C Soares, W M Vollmer, S C Cavalcante, et al.
Lancet (London, England)|March 31, 1998
Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infectionN A Halsey, J S Coberly, J Desormeaux, et al.
JAMA|March 25, 2000
Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study GroupF Gordin, R E Chaisson, J P Matts, et al.
The Journal of Antimicrobial Chemotherapy|November 26, 2020
Nevirapine pharmacokinetics in HIV-infected persons receiving rifapentine and isoniazid for TB preventionA T Podany, J Leon-Cruz, J Hakim, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 17, 2009
Tuberculosis incidence among contacts of active pulmonary tuberculosisM Cailleaux-Cezar, D de A Melo, G M Xavier, et al.
Pageof 23